[Form 4] Tempus AI, Inc. Insider Trading Activity
Rhea-AI Filing Summary
Tempus AI director David R. Epstein reported a sale of 250 shares of Class A common stock on 09/02/2025 at $73.64 per share. The Form 4 shows the transaction was executed under a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2024. After the reported sale, Epstein beneficially owned 27,041 shares, held directly. The filing was submitted by one reporting person and signed by an attorney-in-fact on 09/04/2025.
Positive
- None.
Negative
- None.
Insights
TL;DR: Director sale appears orderly and covered by a 10b5-1 plan, indicating pre-arranged trading rather than ad hoc insider selling.
The disclosed sale of 250 shares under a Rule 10b5-1 plan suggests the director followed an established, pre-approved trading arrangement adopted 08/27/2024. The remaining direct ownership of 27,041 shares maintains substantial alignment with shareholders. Filing by one reporting person and a signature via attorney-in-fact are routine disclosures and show formal compliance with Section 16 reporting requirements.
TL;DR: Transaction size is small relative to reported holdings, so impact on ownership and market is likely negligible.
The sale of 250 shares at $73.64 represents a modest disposition relative to 27,041 shares held after the trade. The explicit note that the trade was pursuant to a 10b5-1 plan reduces signals of opportunistic insider timing. From a market-impact perspective, the trade is immaterial in size and informational content beyond confirming active, disclosed insider trading under a pre-established plan.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Comnmon Stock | 250 | $73.64 | $18K |
Footnotes (1)
- F1. This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 27, 2024.
AI-generated analysis. How Rhea-AI works. Not financial advice.